New DLG2 Isoform in Renal Oncocytoma
Author Information
Author(s): Dmitry Zubakov, Zorica Stupar, Gyula Kovacs
Primary Institution: Ruprecht-Karls-University, Heidelberg, Germany
Hypothesis
The study aims to identify molecular markers for renal oncocytoma through gene expression profiling.
Conclusion
The new isoform of DLG2 is a promising candidate gene for molecular differential diagnostics of renal oncocytoma.
Supporting Evidence
- The new isoform of DLG2 is specifically upregulated in renal oncocytoma.
- The known DLG2 gene is downregulated in renal oncocytoma.
- The study identified a single mRNA transcript for FLJ37266 and DLG2 genes.
Takeaway
Researchers found a new version of a gene called DLG2 that is mostly found in a type of kidney tumor called renal oncocytoma, which can help doctors tell it apart from other tumors.
Methodology
The study used Affymetrix microarray hybridization and semiquantitative RT-PCR to analyze gene expression in renal oncocytomas.
Limitations
The functional role of the new DLG2 isoform in renal oncocytomas is not yet known.
Participant Demographics
Patients who underwent tumor nephrectomy for renal oncocytoma.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website